Literature DB >> 2897464

Reversible pulmonary disease and eosinophilia associated with sulphasalazine.

A Jordan1, R E Cowan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897464      PMCID: PMC1291551          DOI: 10.1177/014107688808100418

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Pulmonary infiltrates and eosinophilia associated with sulfasalazine.

Authors:  K K Wang; B A Bowyer; C R Fleming; K W Schroeder
Journal:  Mayo Clin Proc       Date:  1984-05       Impact factor: 7.616

2.  Bronchial disease in ulcerative colitis.

Authors:  T Higenbottam; G M Cochrane; T J Clark; D Turner; R Millis; W Seymour
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

3.  Sulfasalazine-induced pulmonary disease.

Authors:  R H Moseley; K W Barwick; K Dobuler; V A DeLuca
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

4.  Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors:  J R Collins
Journal:  South Med J       Date:  1968-04       Impact factor: 0.954

5.  Pulmonary function in patients with inflammatory bowel disease.

Authors:  O E Eade; C L Smith; J R Alexander; P J Whorwell
Journal:  Am J Gastroenterol       Date:  1980-02       Impact factor: 10.864

  5 in total
  1 in total

Review 1.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.